Caroline Vermeren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Caroline Vermeren has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amal Freigoun
School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen Scotland, UK
1 shared publication Christelle Q. Kanda
School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen Scotland, UK
1 shared publicationElissa Burr
School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen Scotland, UK
1 shared publication- Hazel Robinson
School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen Scotland, UK
1 shared publication - Luca Foley
School of Medicine, Medical Sciences and Nutrition University of Aberdeen Aberdeen Scotland, UK
1 shared publication - Matthew Everest
School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB24 2ZD
1 shared publication
Latest Publications
- Open Access
- 3 March 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (3) , e71673
Male Breast Cancer: Growing Insights and Continuing Challenges
Background: Breast cancer (BC) in men accounts for less than 1% of all BC diagnoses worldwide. Despite its low incidence, the number of men being diagnosed is increasing. Historically perceived as a predominantly female disease, BC in men has received comparatively limited attention. Aim: This review aims to examine how BC manifests in men and explored the impact of stigma and awareness on diagnosis and prognosis. Methods: A narrative review of current literature was undertaken, including epidemiological studies, clinical research and psychosocial analyses relating to male BC. Results: Male BC shares several pathological and molecular features with female BC, but notable differences exist in presentation, tumour biology and treatment considerations. Men are more likely to present at a later stage of disease, often due to low awareness and misconception that BC affects only women. Stigma and limited targeted education further contribute to delayed medical consultation. Discussion: Although understanding of male BC has improved, challenges remain in early detection and awareness. The gendered perception of BC may discourage men from seeking timely medical advice, leading to more advanced disease at diagnosis and potentially poorer outcomes. Conclusion: Addressing stigma, increasing public and professional education and promoting clinical research inclusive of men are essential to improving timely diagnosis and outcomes.
- 3 March 2026
- Published by Wiley in Cancer Medicine
- Vol. 15 (3) , e71673
Open AccessMale Breast Cancer: Growing Insights and Continuing Challenges
Background: Breast cancer (BC) in men accounts for less than 1% of all BC diagnoses worldwide. Despite its low incidence, the number of men being diagnosed is increasing. Historically perceived as a predominantly female disease, BC in men has received comparatively limited attention. Aim: This review aims to examine how BC manifests in men and explored the impact of stigma and awareness on diagnosis and prognosis. Methods: A narrative review of current literature was undertaken, including epidemiological studies, clinical research and psychosocial analyses relating to male BC. Results: Male BC shares several pathological and molecular features with female BC, but notable differences exist in presentation, tumour biology and treatment considerations. Men are more likely to present at a later stage of disease, often due to low awareness and misconception that BC affects only women. Stigma and limited targeted education further contribute to delayed medical consultation. Discussion: Although understanding of male BC has improved, challenges remain in early detection and awareness. The gendered perception of BC may discourage men from seeking timely medical advice, leading to more advanced disease at diagnosis and potentially poorer outcomes. Conclusion: Addressing stigma, increasing public and professional education and promoting clinical research inclusive of men are essential to improving timely diagnosis and outcomes.